Melcare Biomedical develops and manufactures therapeutic products for skin, wound and eye care using standardised medical honeys for a global market. Our products are for families, patients and clinicians.
We are committed to a healthy sustainable environment and protection of wilderness. Most of our ingredients are plant derived and our Leptospermum sp honey comes from a small tree in wild forests. The honey used in every individual batch is traceable to the beekeepers and forest location of the leptospermum plants that produced the nectar for the honey.
Our President and Chief Executive Officer, Anthony Moloney, has been a key driver in medical honey research since 1992. Early research helped identify which plant species were most suitable for medical use. Mr Moloney then developed the Medihoney® brand and product range which were commercialised by Australia’s Capilano Honey Ltd in 1999.
Melcare Biomedical continues to drive international research into the medical use of standardised honeys. We also strongly support the broader medical use of honeys in developing countries through empowering them with local capability.
ISO 13485 Medical Device Quality Management System
CE Certificate -
Full Quality Assurance Procedures - Provisions of Annex II, section 3 with the exemption of section 4 of the Council Directive 93/42/EEC on medical devices. (Therapeutic Good Administration, Australia)
Conformity Assessment Certificate - Full Quality Assurance Procedures Schedule 3, Part 1 (excluding clause 1.6) of the Therapeutic Goods (Medical Devices) Regulations 2002. (Therapeutic Good Administration, Australia)
Medihoney® a brand of Comvita Ltd (NZ)